Cargando…

Serum Paraoxonase/Arylesterase Activity and Oxidative Stress Status in Children with Metabolic Syndrome

Objective: This study aimed to measure paraoxonase/arylesterase activities and to evaluate the total oxidant and antioxidant capacities in obese children and in children with metabolic syndrome (MetS). Methods: A total of 151 children of comparable ages (13.23±1.96 years, 13.45±1.85 years and 13....

Descripción completa

Detalles Bibliográficos
Autores principales:	Eren, Erdal, Abuhandan, Mahmut, Solmaz, Abdullah, Taşkın, Abdullah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293645/ https://www.ncbi.nlm.nih.gov/pubmed/25241610 http://dx.doi.org/10.4274/jcrpe.1454

Ejemplares similares

Serum Paraoxonase, Arylesterase, and Glutathione-S-Transferase Activities and Oxidative Stress Levels in Patients with Mushroom Poisoning
por: Eren, Sevki Hakan, et al.
Publicado: (2018)

Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
por: Erdem, Fazile Hatipoglu, et al.
Publicado: (2010)

Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
por: Zinellu, Angelo, et al.
Publicado: (2023)

Total Oxidant Status, Total Antioxidant Status, and Paraoxonase and Arylesterase Activities during Laparoscopic Cholecystectomy
por: Koksal, Hande, et al.
Publicado: (2010)

Evaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic Treatment
por: Güneş, Mehmet, et al.
Publicado: (2016)

Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population
por: Elkiran, Emin T, et al.
Publicado: (2007)

Usefulness of the Measurement of Serum Paraoxonase-1 Arylesterase Activity in the Diagnoses of COVID-19
por: Gabaldó, Xavier, et al.
Publicado: (2022)

Paraoxonase and Arylesterase Activities in Dipper and Non-Dipper Prehypertensive Subjects
por: Yuksel, Murat, et al.
Publicado: (2015)

Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy
por: Ayan, Durmuş, et al.
Publicado: (2019)

Vitamin B6 Supplementation Improves Oxidative Stress and Enhances Serum Paraoxonase/Arylesterase Activities in Streptozotocin-Induced Diabetic Rats
por: Taş, Sibel, et al.
Publicado: (2014)

Paraoxonase and Arylesterase Activities, Lipid Profile, and Oxidative Damage in Experimental Ischemic Colitis Model
por: Unal, Ethem, et al.
Publicado: (2012)

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia
por: Romani, Arianna, et al.
Publicado: (2020)

Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL
por: Schilcher, Irene, et al.
Publicado: (2021)

Paraoxonase Activity and Oxidative Status in Patients with Tinnitus
por: Koç, Sema, et al.
Publicado: (2016)

Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study
por: Meisinger, Christa, et al.
Publicado: (2021)

Paraoxonase and arylesterase activity of serum PON-1 enzyme in psoriatic patients: a systematic review and meta-analysis
por: Bassu, Stefania, et al.
Publicado: (2022)

The Effect of Date Seed (Phoenix dactylifera) Extract on Paraoxonase and Arylesterase Activities in Hypercholesterolemic Rats
por: Takaeidi, Mohammad Reza, et al.
Publicado: (2014)

Total Serum Oxidant/Antioxidant Status and Arylesterase Activity in Recurrent Aphthous Stomatitis
por: Akoglu, Gulsen, et al.
Publicado: (2013)

Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naïve patients
por: Asare, George Awuku, et al.
Publicado: (2018)

Association between Paraoxonase/Arylesterase Activity of Serum PON-1 Enzyme and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Erre, Gian Luca, et al.
Publicado: (2022)

Arylesterase activity is associated with antioxidant intake and paraoxonase-1 (PON1) gene methylation in metabolic syndrome patients following an energy restricted diet
por: de la Iglesia, Rocio, et al.
Publicado: (2014)

Arylesterase Phenotype-Specific Positive Association Between Arylesterase Activity and Cholinesterase Specific Activity in Human Serum
por: Aoki, Yutaka, et al.
Publicado: (2014)

Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis
por: Zuin, Marco, et al.
Publicado: (2022)

Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders
por: Piras, Ignazio Stefano, et al.
Publicado: (2021)

An Evaluation of Oxidative Status in Serum and Breast Milk of Mothers Giving Birth Prematurely and at Full-Term
por: Abuhandan, Mahmut, et al.
Publicado: (2015)

Relationship between Paraoxonase-1 and Arylesterase Enzyme Activities and SYNTAX I and II Scores in Patients with ST-Elevation Myocardial Infarction
por: Sökmen, Erdoğan, et al.
Publicado: (2019)

Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study
por: Reisinger, Alexander C., et al.
Publicado: (2020)

Evaluation of Selenium Levels and Mean Platelet Volume in Patients with Simple Febrile Convulsion
por: Abuhandan, Mahmut, et al.
Publicado: (2014)

Paraoxonase activity in metabolic syndrome in children and adolescents
por: Adhe-Rojekar, Arati, et al.
Publicado: (2018)

Arylesterase activity of paraoxonase 1 (PON1) on HDL(3) and HDL(2): Relationship with Q192R, C-108T, and L55M polymorphisms
por: Valencia C, Sandra Y., et al.
Publicado: (2021)

Mining bacterial genomes for novel arylesterase activity
por: Wang, Lijun, et al.
Publicado: (2010)

Evaluation of Pre-Treatment and Post-Treatment S100B, Oxidant and Antioxidant Capacity in Children with Diabetic Ketoacidosis
por: Kaya, Cemil, et al.
Publicado: (2015)

Serum Paraoxonase 1 Activity and Oxidative Stress in Pediatric Patients with Pulmonary Tuberculosis
por: Torun, Emel, et al.
Publicado: (2014)

Low Paraoxonase 1 Arylesterase Activity and High von Willebrand Factor Levels are Associated with Severe Coronary Atherosclerosis in Patients with Non-Diabetic Stable Coronary Artery Disease
por: Ding, Jieying, et al.
Publicado: (2014)

Oxidative Stress and Alterations of Paraoxonases in Atopic Dermatitis
por: Simonetti, Oriana, et al.
Publicado: (2021)

Association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescents
por: Zaki, Moushira Erfan, et al.
Publicado: (2014)

Serum Paraoxonase 1 Activity Status in Patients with Liver Disorders
por: Kedage, Vivekananda, et al.
Publicado: (2010)

Evaluation of Paraoxonase Activity in Children With Nephrotic Syndrome
por: Hashemi, Mohammad, et al.
Publicado: (2013)

Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene
por: Idrees, Muhammad, et al.
Publicado: (2018)

PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways
por: Camps, Jordi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3uo510l9jt6segupucn2f7sphq